Data / Drug companies / Tablet, orally disintegrating
Companies that list tablet, orally disintegrating products: 132 companies and 560 products in the FDA NDC directory
The FDA National Drug Code Directory lists 560 products that are tablet, orally disintegrating products from 132 companies. The ten largest listers hold 27.3% of them, and the newest started marketing on August 6, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies
- 132
- Products
- 560
- Drugs by generic name
- 37
- Main marketing category
- Generic drugs (ANDA)
Companies that list tablet, orally disintegrating products
Ranked by number of products in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Aurobindo Pharma Limited | 20 | tablet, orally disintegrating | Generic drugs (ANDA) | May 15, 2014 |
| TRP Company | 20 | tablet, orally disintegrating | Unapproved homeopathic products | April 30, 2025 |
| Par Health USA, LLC | 19 | tablet, orally disintegrating | Generic drugs (ANDA) | December 16, 2015 |
| NuCare Pharmaceuticals,Inc. | 15 | tablet, orally disintegrating | Generic drugs (ANDA) | April 27, 2021 |
| Alembic Pharmaceuticals Inc. | 14 | tablet, orally disintegrating | Generic drugs (ANDA) | March 2, 2026 |
| Alembic Pharmaceuticals Limited | 14 | tablet, orally disintegrating | Generic drugs (ANDA) | March 2, 2026 |
| Bryant Ranch Prepack | 14 | tablet, orally disintegrating | Generic drugs (ANDA) | June 19, 2025 |
| Teva Pharmaceuticals USA, Inc. | 14 | tablet, orally disintegrating | Generic drugs (ANDA) | March 2, 2022 |
| Catalent U.k. Swindon Zydis Limited | 12 | tablet, orally disintegrating | Drugs for further processing | February 1, 2023 |
| Jubilant Cadista Pharmaceuticals Inc. | 11 | tablet, orally disintegrating | Generic drugs (ANDA) | September 17, 2015 |
| Neos Therapeutics Brands, LLC | 9 | tablet, orally disintegrating | New drug applications (NDA) | June 20, 2017 |
| Neos Therapeutics, LP | 9 | tablet, orally disintegrating | Authorized generics (NDA) | July 1, 2026 |
| Adare Pharmaceuticals Inc | 8 | tablet, orally disintegrating | Drugs for further processing | May 16, 2019 |
| Amneal Pharmaceuticals of New York LLC | 8 | tablet, orally disintegrating | Generic drugs (ANDA) | December 27, 2018 |
| Aurobindo Pharma Limited | 8 | tablet, orally disintegrating | Generic drugs (ANDA) | February 18, 2026 |
| Aurohealth LLC | 8 | tablet, orally disintegrating | Generic drugs (ANDA) | June 18, 2022 |
| Bionpharma Inc. | 8 | tablet, orally disintegrating | Generic drugs (ANDA) | July 1, 2026 |
| Macleods Pharmaceuticals Limited | 8 | tablet, orally disintegrating | Generic drugs (ANDA) | February 27, 2015 |
| Torrent Pharmaceuticals Limited | 8 | tablet, orally disintegrating | Generic drugs (ANDA) | January 8, 2026 |
| A-S Medication Solutions | 7 | tablet, orally disintegrating | Generic drugs (ANDA) | April 12, 2010 |
| Advanced Rx of Tennessee, LLC | 7 | tablet, orally disintegrating | Generic drugs (ANDA) | October 15, 2025 |
| Chartwell RX, LLC | 7 | tablet, orally disintegrating | Generic drugs (ANDA) | September 20, 2024 |
| Proficient Rx LP | 7 | tablet, orally disintegrating | Generic drugs (ANDA) | April 12, 2010 |
| Rising Pharma Holdings, Inc. | 7 | tablet, orally disintegrating | Generic drugs (ANDA) | July 1, 2013 |
| Square Pharmaceuticals Limited | 7 | tablet, orally disintegrating | Generic drugs (ANDA) | November 15, 2022 |
| Advagen Pharma Ltd | 6 | tablet, orally disintegrating | Generic drugs (ANDA) | May 21, 2026 |
| Dr. Reddy's Laboratories Inc. | 6 | tablet, orally disintegrating | Generic drugs (ANDA) | May 19, 2021 |
| Dr. Reddy's Laboratories Limited | 6 | tablet, orally disintegrating | Generic drugs (ANDA) | January 11, 2013 |
| Edenbridge Pharmaceuticals LLC. | 6 | tablet, orally disintegrating | New drug applications (NDA) | June 12, 2026 |
| Glenmark Pharmaceuticals Inc., USA | 6 | tablet, orally disintegrating | Generic drugs (ANDA) | July 1, 2013 |
| Golden State Medical Supply, Inc. | 6 | tablet, orally disintegrating | Generic drugs (ANDA) | July 1, 2013 |
| Orexo US, Inc. | 6 | tablet, orally disintegrating | New drug applications (NDA) | December 11, 2014 |
| Teva Pharmaceuticals, Inc. | 6 | tablet, orally disintegrating | Generic drugs (ANDA) | December 8, 2025 |
| Walgreen Company | 6 | tablet, orally disintegrating | Generic drugs (ANDA) | May 13, 2022 |
| Amerisyn LLC | 5 | tablet, orally disintegrating | Generic drugs (ANDA) | August 6, 2026 |
| Amici Pharma, Inc. | 5 | tablet, orally disintegrating | Generic drugs (ANDA) | April 1, 2026 |
| Asclemed USA, Inc. | 5 | tablet, orally disintegrating | Generic drugs (ANDA) | July 1, 2013 |
| Janssen Pharmaceuticals, Inc. | 5 | tablet, orally disintegrating | New drug applications (NDA) | April 2, 2003 |
| Preferred Pharmaceuticals Inc. | 5 | tablet, orally disintegrating | Generic drugs (ANDA) | June 11, 2026 |
| Sun Pharmaceutical Industries, Inc. | 5 | tablet, orally disintegrating | Generic drugs (ANDA) | August 6, 2010 |
| Viona Pharmaceuticals Inc | 5 | tablet, orally disintegrating | Generic drugs (ANDA) | August 7, 2022 |
| Actavis Pharma, Inc. | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | March 17, 2010 |
| Ajanta Pharma USA Inc. | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | January 19, 2021 |
| Apotex Corp. | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | October 24, 2011 |
| AvKARE | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | November 17, 2025 |
| Bryant Ranch Prepack | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | October 24, 2011 |
| Cardinal Health 107, LLC | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | October 31, 2024 |
| Cycle Pharmaceuticals Ltd | 4 | tablet, orally disintegrating | New drug applications (NDA) | June 30, 2026 |
| GlaxoSmithKline LLC | 4 | tablet, orally disintegrating | New drug applications (NDA) | June 5, 2009 |
| H2-Pharma, LLC | 4 | tablet, orally disintegrating | New drug applications (NDA) | September 1, 2001 |
| Hec Pharm USA Inc. | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | March 17, 2026 |
| Lannett Company, Inc. | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | May 30, 2023 |
| Mylan Pharmaceuticals Inc. | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | August 16, 2023 |
| Northwind Health Company, LLC | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | August 8, 2022 |
| Organon LLC | 4 | tablet, orally disintegrating | New drug applications (NDA) | June 1, 2021 |
| Remedyrepack Inc. | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | June 29, 2026 |
| ScieGen Pharmaceuticals, Inc. | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | November 30, 2015 |
| Strides Pharma Science Limited | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | April 11, 2022 |
| Unichem Pharmaceuticals (USA), Inc. | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | March 7, 2017 |
| Zydus Pharmaceuticals USA Inc. | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | November 30, 2018 |
| Advanz Pharma (US) Corp. | 3 | tablet, orally disintegrating | New drug applications (NDA) | June 1, 2006 |
| Bayer HealthCare LLC. | 3 | tablet, orally disintegrating | New drug applications (NDA) | December 12, 2006 |
| CVS Pharmacy | 3 | tablet, orally disintegrating | Generic drugs (ANDA) | February 1, 2021 |
| CVS Woonsocket Prescription Center, Incorporated | 3 | tablet, orally disintegrating | Generic drugs (ANDA) | October 6, 2025 |
| Direct_Rx | 3 | tablet, orally disintegrating | Generic drugs (ANDA) | August 22, 2025 |
| Ingenus Pharmaceuticals, LLC | 3 | tablet, orally disintegrating | Authorized generics (NDA) | September 15, 2025 |
| Meditrend, Inc. DBA Progena Professional Formulations | 3 | tablet, orally disintegrating | Unapproved homeopathic products | September 1, 2024 |
| PD-Rx Pharmaceuticals, Inc. | 3 | tablet, orally disintegrating | Generic drugs (ANDA) | April 12, 2010 |
| Proficient Rx LP | 3 | tablet, orally disintegrating | Generic drugs (ANDA) | March 7, 2017 |
| Rising Pharma Holdings, Inc. | 3 | tablet, orally disintegrating | Generic drugs (ANDA) | January 8, 2025 |
| Sportpharm LLC | 3 | tablet, orally disintegrating | Generic drugs (ANDA) | March 5, 2020 |
| St. Mary's Medical Park Pharmacy | 3 | tablet, orally disintegrating | Generic drugs (ANDA) | October 15, 2025 |
| Stallergenes | 3 | tablet, orally disintegrating | Biologics (BLA) | April 30, 2014 |
| Sun Pharmaceutical Industries, Inc. | 3 | tablet, orally disintegrating | Generic drugs (ANDA) | December 15, 2014 |
| Amazon.com Services LLC | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | March 4, 2021 |
| BluePoint Laboratories | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | March 13, 2014 |
| Chain Drug Consortium, LLC | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | April 11, 2018 |
| Coupler LLC | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | June 17, 2025 |
| Dolgencorp, Inc. (dollar General & Rexall) | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | June 17, 2021 |
| Foundation Consumer Healthcare | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | October 31, 2024 |
| HF Acquisition Co LLC, DBA HealthFirst | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | March 31, 2020 |
| Hawaii Repack, Inc. | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | April 12, 2010 |
| Innovus Pharmaceuticals, Inc. | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | June 4, 2022 |
| Ipca Laboratories Limited | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | June 19, 2025 |
| Kenvue Brands LLC | 2 | tablet, orally disintegrating | New drug applications (NDA) | January 20, 2014 |
| Kroger Company | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | June 4, 2021 |
| L. Perrigo Company | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | September 11, 2020 |
| Lupin Pharmaceuticals,Inc. | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | April 6, 2015 |
| Marco Pharma International LLC. | 2 | tablet, orally disintegrating | Unapproved homeopathic products | March 1, 1992 |
| Nestmann Pharma GmbH | 2 | tablet, orally disintegrating | Drugs for further processing | March 1, 1992 |
| NorthStar Rx LLC | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | April 27, 2021 |
| Panacea Biotec Limited | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | January 17, 2017 |
| Pfizer Laboratories Div Pfizer Inc | 2 | tablet, orally disintegrating | New drug applications (NDA) | March 5, 2020 |
| Safeway | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | September 20, 2023 |
| Sun Pharmaceutical Industries, Inc. | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | August 2, 2007 |
| Tenshi Kaizen Pvt Ltd | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | May 7, 2024 |
| Wal-Mart Stores Inc | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | April 11, 2018 |
| Walmart Inc. | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | January 14, 2026 |
| Zydus Lifesciences Limited | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | November 30, 2018 |
| Zydus Lifesciences Limited | 2 | tablet, orally disintegrating | Generic drugs (ANDA) | May 16, 2013 |
Drugs most often listed
| Drug | Products here | Companies listing it |
|---|---|---|
| Acetaminophen | 1 | 214 |
| Loratadine | 46 | 125 |
| Cetirizine hydrochloride | 13 | 119 |
| Fexofenadine hydrochloride | 1 | 65 |
| Cyclobenzaprine hydrochloride | 1 | 61 |
| Lansoprazole | 4 | 58 |
| Ondansetron | 98 | 52 |
| Lamotrigine | 40 | 51 |
| Olanzapine | 57 | 49 |
| Aripiprazole | 14 | 49 |
| Risperidone | 31 | 43 |
| Mirtazapine | 18 | 42 |
| Carbidopa and levodopa | 6 | 41 |
| Meclizine hydrochloride | 2 | 41 |
| Alprazolam | 8 | 37 |
| Clonazepam | 25 | 36 |
| Donepezil hydrochloride | 4 | 34 |
| Rizatriptan benzoate | 28 | 25 |
| Hyoscyamine sulfate | 9 | 24 |
| Zolmitriptan | 14 | 22 |
| Prednisolone sodium phosphate | 6 | 16 |
| Clozapine | 16 | 13 |
| Metoclopramide hydrochloride | 2 | 13 |
| Selegiline hydrochloride | 1 | 12 |
| Desloratadine | 2 | 11 |
| Nilotinib | 2 | 10 |
| Vardenafil | 2 | 6 |
| Methylphenidate | 3 | 5 |
| Amphetamine | 12 | 4 |
| Allergy relief | 3 | 4 |
| Buprenorphine hydrochloride and naloxone hydrochloride | 12 | 3 |
| Rimegepant sulfate | 3 | 2 |
| Amphetamine extended-release | 6 | 1 |
| Methylphenidate extended-release | 3 | 1 |
| Fingolimod lauryl sulfate | 2 | 1 |
| Rizatriptan benzoate odt | 2 | 1 |
| Alprazolam odt c-iv | 1 | 1 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.